Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7485302 Treatment with anti-ErbB2 antibodies and chemotherapeutic agents

Patent 7485302 was granted and assigned to Genentech on February, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Genentech
Genentech
0
Date Filed
May 5, 2006
0
Date of Patent
February 3, 2009
0
Patent Application Number
11429043
0
Patent Citations Received
‌
US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer
0
‌
US Patent 11654105 Subcutaneous HER2 antibody formulations
0
‌
US Patent 11655305 Treatment of metastatic breast cancer
0
‌
US Patent 11713358 Chimeric polypeptide assembly and methods of making and using the same
0
‌
US Patent 11981744 Chimeric polypeptide assembly and methods of making and using the same
0
‌
US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer
0
‌
US Patent 12110341 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
0
Patent Inventor Names
Leonard G. Presta
0
Mark Sliwkowski
0
Camellia W. Adams
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7485302
0
Patent Primary Examiner
‌
Alana M. Harris
0

Find more entities like US Patent 7485302 Treatment with anti-ErbB2 antibodies and chemotherapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.